Morningstar Investment Services LLC decreased its holdings in Cigna Corp (NYSE:CI) by 5.6% during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,450 shares of the health services provider’s stock after selling 2,337 shares during the quarter. Morningstar Investment Services LLC’s holdings in Cigna were worth $7,399,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also bought and sold shares of the stock. State of Michigan Retirement System lifted its holdings in Cigna by 10.2% during the second quarter. State of Michigan Retirement System now owns 94,274 shares of the health services provider’s stock valued at $17,691,000 after purchasing an additional 8,704 shares in the last quarter. Duality Advisers LP purchased a new position in Cigna during the second quarter valued at approximately $3,506,000. Eads & Heald Wealth Management lifted its holdings in Cigna by 4.8% during the second quarter. Eads & Heald Wealth Management now owns 1,316 shares of the health services provider’s stock valued at $247,000 after purchasing an additional 60 shares in the last quarter. Sciencast Management LP purchased a new position in Cigna during the second quarter valued at approximately $1,887,000. Finally, Pacer Advisors Inc. purchased a new position in Cigna during the second quarter valued at approximately $6,381,000. 88.53% of the stock is currently owned by institutional investors.
Several brokerages have weighed in on CI. UBS Group lowered their price target on shares of Cigna from $252.00 to $246.00 and set a “buy” rating on the stock in a report on Friday, June 5th. SunTrust Banks lowered their target price on shares of Cigna from $280.00 to $240.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Morgan Stanley boosted their target price on shares of Cigna from $251.00 to $258.00 and gave the stock an “overweight” rating in a report on Monday, April 13th. Deutsche Bank lowered their target price on shares of Cigna from $288.00 to $279.00 and set a “buy” rating on the stock in a report on Monday, May 4th. Finally, SVB Leerink lowered their target price on shares of Cigna from $220.00 to $207.00 and set a “market perform” rating on the stock in a report on Friday. Two research analysts have rated the stock with a sell rating, three have assigned a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $244.00.
NYSE:CI traded down $5.78 during mid-day trading on Friday, reaching $172.69. The company’s stock had a trading volume of 2,452,731 shares, compared to its average volume of 1,887,986. Cigna Corp has a 1 year low of $118.50 and a 1 year high of $224.64. The stock has a fifty day moving average of $184.19 and a 200-day moving average of $189.90. The firm has a market capitalization of $63.72 billion, a PE ratio of 12.29, a price-to-earnings-growth ratio of 0.85 and a beta of 0.70. The company has a quick ratio of 0.67, a current ratio of 0.74 and a debt-to-equity ratio of 0.67.
Cigna (NYSE:CI) last released its quarterly earnings data on Thursday, July 30th. The health services provider reported $5.81 earnings per share for the quarter, topping the Zacks’ consensus estimate of $5.15 by $0.66. Cigna had a net margin of 3.41% and a return on equity of 15.89%. The company had revenue of $39.27 billion during the quarter, compared to analyst estimates of $37.93 billion. During the same period in the prior year, the firm earned $4.30 earnings per share. The firm’s revenue for the quarter was up 14.2% compared to the same quarter last year. On average, analysts expect that Cigna Corp will post 18.49 earnings per share for the current year.
Cigna Company Profile
Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.
Featured Article: Dead Cat Bounce
Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.